Cai, Q., Chen, F., Wang, T., Luo, F., Liu, X., Wu, Q., He, Q., Wang, Z., Liu, Y., Liu, L., Chen, J., & Xu, L. (2020). Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes care, 43(7), 1392–1398. 

https://doi.org/10.2337/dc20-0576

https://care.diabetesjournals.org/content/43/7/1392.long

Smith College

Ohio State University, Columbus

- Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Diabetes Care Papers Related to COVID-19 Patient Comorbidities

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

Mirani, M., Favacchio, G., Carrone, F., Betella, N., Biamonte, E., Morenghi, E., . . . Lania, A. G. (2020). Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy. Diabetes Care, 43(12), 3042-3049. doi:10.2337/dc20-1340

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Learn Before

Related